ozoralizumab
pathoantigen
olaratumab
certolizumab
tislelizumab
brolucizumab
Rh-positive blood type
lenzilumab
counterimmune
Rh positive
ravulizumab
gevokizumab
pidilizumab
interhombomeric
talizumab
immunoagglutination
rhabdomyoblastic
preimmune
Duffy antigen
belimumab
bezlotoxumab
immunoabsorbent
perakizumab
immunovaccine
Rhesus factor
immunodeposit
agonistic monoclonal antibody
rheopectic
-axo-
soravtansine
fontolizumab
immunospecific
-o-
isoantibody
vepalimomab
rheotactic
rhopalid
immunoprevention
immunonaive
inflammosuppression
idiospecific
antiglucagon
conatumumab
immunize
antigenically
immunome
inflammasome
histocompatibility antigen
countercorrelated